Injective vs Story — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,76T 24h volume), while Story trades at Rp5,692 (market cap Rp1,92T, Rp231,18M 24h volume). The key difference: Injective is far larger — about 4.8× Story's market cap, and Injective's circulating supply is 100M INJ versus 356,6M IP for Story. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Story for 22 Days on average.
| INJ | IP | |
|---|---|---|
Market Cap | Rp9,29T | Rp1,92T |
Volume (24h) | Rp1,76T | Rp231,18M |
Circulating Supply | 100M INJ | 356,6M IP |
Typical Hold Time | 36 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
The IP token currently holds a market capitalization of Rp1,92T with a circulating supply of 356,6jt tokens. The asset shows moderate holding behavior with an average hold time of 22 days, indicating some investor patience. Recent trading activity appears stable with no extreme volatility reported in the latest data. The token's ecosystem shows ongoing development activity, though specific protocol updates require further verification from blockchain explorers.
Overall outlook remains cautiously optimistic given the established market cap and stable holding patterns. Key opportunities include potential ecosystem growth and increased utility adoption. Major risks include typical crypto market volatility and regulatory uncertainties that could impact token performance. Investors should monitor on-chain metrics and exchange liquidity closely.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Story is a Layer 1 blockchain designed to serve as a foundation for intellectual property (IP) on the internet. It enables creators to register, license, and monetize their IP assets seamlessly. By leveraging blockchain technology, Story offers a transparent and efficient framework for IP attribution, licensing, and commercialization.
Read more on IP →